Welcome to the inaugural issue of the Hip Hope Network Research Pillar Newsletter! The newsletter will be a biannual publication, with a goal of bringing together recent publications, highlights, and news regarding pediatric orthopedics. We hope to bring the global hip research community together, provide some tips and tricks for research conduct, highlight innovative and exciting new research in the field of pediatric hip, and highlight current studies from collaborating registries and study groups. If you have ideas for newsletter content you would like to see, please don’t hesitate to reach out to us! We look forward to collaborating with you all in the coming months and years. - Dr. Emily Schaeffer & Dr. Woody Sankar, Research Pillar Co-Leads | NEWSLETTER CONTENTS - Welcome from Dr. Emily Schaeffer & Dr. Woody Sankar, Research Pillar Co-Leads
- Save-the-date for the 2nd Annual All-Members Meeting!
- Research Opportunity - Rare Hip Conditions Registry (RHCR)
- Literature Highlight: The contralateral hip in slipped capital femoral epiphysis: is there an easy-to-use algorithm to support a decision for prophylactic fixation?
- Feature: Follow-up Strategies for Longitudinal Research
- Research Highlights: Global Research Registries
- Publication Highlights
- Join In - DocMatter Lower Extremities Discussion Channel moderated by Hip Hope Network!
| | Tuesday, April 18, 2023, 1:00 PM Pacific Time (US & Canada) WEBINAR - Networking, registries, & big data: How GroupThink helps your patients This event is sponsored by OrthoPediatrics & supported by the Hip Hope Network. RSVP using the registration link below! Register Here | | Saturday, April 29, 2023, 9:00 AM-11:30 AM Central Time (US & Canada) ANNUAL MEETING - Hip Hope Network 2nd Annual All-Members Join us in-person in Nashville, Tennessee, or remotely via Zoom for our 2nd Annual All-Members Meeting! The event will include featured speakers, information about ongoing and upcoming opportunities, and updates from the Network leadership. The event space is generously provided by POSNA. Register Now | | CALL FOR INTERESTED INVESTIGATORS | Rare Hip Conditions Registry We are in the process of developing the Rare Hip Conditions Registry (RHCR) as the newest member of the Hippy Global Registry Program. RHCR is a broad registry housing 29 individual hip conditions as subregistries. We are piloting RHCR initially with 3 conditions: the hip in spinal muscular atrophy (SMA), the hip in Rett Syndrome, and the hip in Down Syndrome. If you are interested in joining (or championing a particular hip condition), we would love to hear from you! Interested investigators can contribute to as many or as few of the included conditions as desired. Please complete the RHCR investigator interest survey to indicate your interest. Investigator Survey | | Follow-up Strategies in Longitudinal Research By: Dr. Woody Sankar Need for improved patient retention It is critical for any orthopaedic study evaluating the long-term outcome of a disease (treated or untreated) to have high follow-up rates. When large numbers of participants are lost to follow-up, the study power is reduced, generalizability may become limited, and bias can be introduced if those lost differ from those that remain in the study. Zelle et al determined that in more than one-quarter of fifty simulated orthopaedic trials, the results switched from significant to non-significant when loss to follow-up rates were 20%. The authors recommended that researchers aim to achieve at least 80% follow-up rates in any long-term study. Reaching this mark, however, can be a significant challenge, especially in younger patients who are notably transient, often relocating for higher education or vocation during the study period. These challenges transcend the particular pediatric hip disease in question. As such, improving follow-up rates should be a common goal amongst all study groups within the Hip Hope Network. Experience from other large multi-center study groups in adult orthopaedic surgery, especially the Multicenter Orthopaedic Outcomes Network (MOON) study of ACL reconstruction, can offer important lessons for how best to improve follow-up rates. Clear from all of these studies is the need for a coordinated and organized protocol for achieving patient retention. Opportunities to improve follow-up The first opportunity to improve long-term follow-up rates actually occurs at the time of initial enrollment. The more the treating physician touts the importance of the study at the outset—describing its rationale in context, how critical follow-up information is, and how it can help children and adolescents in the future—the more likely the patient/family is to “buy in” and feel like they are a part of something bigger. Although they run the risk of adding to “oversaturation”, regular study updates or newsletters through email or social media can help maintain study interest as years pass—a strategy well-employed by the famous Framingham Heart Study. Initial enrollment is also the time to collect as much contact information as possible under the particular study’s ethics/IRB approval including email addresses and cell phone numbers of patients (if applicable) and family members when possible. More permanent email addresses (Gmail, Yahoo., etc) are preferred over email addresses tied to schools, as the latter are more likely to become obsolete. Regular monitoring is key Regular monitoring by either the local or central coordinating site can help identify patients who have recently missed follow-up appointments and are therefore at risk for being lost to follow-up. Many of these patients can be recaptured easily through early identification and direct contact by the local site’s scheduling team. For patients with larger gaps in follow-up, MOON and other adult studies have found that central site follow-up coordination is preferred over local site at least to start. Most local sites have research assistants and coordinators that may turn-over at higher frequency than central sites, which tend to have more stable study teams. However, the feasibility of this approach may be limited, particularly in truly global collaborations, where vast differences in local clinical procedures, customs and languages is likely. Use an algorithm for patient contact Regardless, a clear algorithm for how to contact missing patients is critical, as is an explicit definition for when a patient is truly deemed to be officially “lost”. These algorithms typically include attempts at contact (via email or phone) at regular intervals (e.g., once a week) a predetermined number of times, and logging these attempts to avoid confusion. Phone contact should be attempted at different times of the day (including weekends) with caller IDs associated with the health care center rather than unknown or blocked numbers which are less likely to be answered. Whenever a patient is reached, contact information should be updated and any shorter questionnaires should be administered at that time in case the patient doesn’t respond in the future. If the patient fails to respond to a number of attempts, “escalating” the caller/emailer from a central research coordinator, to the local (and hopefully familiar) advanced practice provider, and eventually to the surgeon him or herself can be extremely helpful. Even the most preoccupied patient is unlikely to ignore a phone call or an email from their treating physician. However, it is important to obtain all necessary ethical approval prior to implementing each of these approaches. Additional opportunities Ultimately, tracking down individual patients in order to get in-person clinical exams and written surveys is expensive from both a cost and labor standpoint. When feasible, telemedicine offers improving opportunities to follow-up with patients who may have moved beyond the local area or who are otherwise unable to easily travel back for an appointment. Radiographs, when necessary, can be obtained locally and uploaded through a number of different platforms which interface with most centers’ EMR and PACS systems. Moving forward, long-term studies should focus on outcomes that can easily be obtained through automated email surveys, text-based queries, or brief telephone questionnaires, rather than detailed clinical visits. References Booker et al. A systematic review of the effect of retention methods in population-based cohort studies. BMC Public Health. 2011;11:249. https://doi.org/10.1186/1471-2458-11-249 Madden et al. Predicting and preventing loss to follow-up of adult trauma patients in randomized controlled trials: An example from the FLOW trial. J Bone Joint Surg Am. 2017;99:1086-1092. DOI: 10.2106/JBJS.16.00900 Marx et al. MOON’s strategy for obtaining over eighty percent follow-up at 10 years following ACL reconstruction. J Bone Joint Surg Am. 2022:104:e7(1-6). DOI: 10.2106/JBJS.21.00166 Zelle et al. Loss of follow-up in orthopaedic trauma: is 80% follow-up still acceptable? J Orthop Trauma. 2013;27(3):1771-81. DOI: 10.1097/BOT.0b013e31825cf367 | The contralateral hip in slipped capital femoral epiphysis: Is there an easy-to-use algorithm to support a decision for prophylactic fixation? The purpose of this study was to identify a specific factor or factors that could support decision-making regarding prophylactic fixation of the contralateral hip in unilateral SCFE. This was a retrospective review of the Swedish Pediatric Orthopaedic Quality Register for all patients diagnosed with unilateral SCFE at the time of initial diagnosis over a six-year period. Patient demographics, slip severity and stability were utilized in a regression analysis to identify risk factors for a contralateral slip. A total of 379 children were identified with a diagnosis of SCFE: 27 with primary bilateral SCFE, 151 with a primary unilateral SCFE who received a concomitant prophylactic fixation, and 201 with a primary unilateral SCFE whose contralateral hip was observed. Of the 201 children with primary unilateral SCFE, 43 went on to develop a slip on the contralateral side. Univariate and multivariate analysis revealed lower chronological age to be the only significantly associated factor with contralateral slip. After 13 years of age, only 1/15 girls and 3/65 boys developed a contralateral slip. Therefore, the authors suggest prophylactic fixation for children under 13 years of age diagnosed with unilateral SCFE. Read More | DOI: 10.1177/18632521221107748 | JOIN US ON DOCMATTER FOR CLINICAL DISCUSSION | The Hip Hope Network is now moderating case-discussion related to hips & lower-extremities in the OrthoPediatrics DocMatter Community! Join in the discussion | | GLOBAL REGISTRY HIGHLIGHTS | International Perthes Study Group (IPSG) IPSG was started in 2012 by an international group of pediatric orthopaedic surgeons and researchers who recognized the need to improve care and treatment outcomes for patients with Perthes’ disease. In formation, over 40 surgeons came together to openly discuss and form consensus on the existing medical evidence, and identify areas to be addressed through a collaborative research program. IPSG’s mission is to advance knowledge of Pethes’ disease and to disseminate objective, evidence-based information to patients, families and the medical community. Today, IPSG has 49 members – doctors and scientists worldwide, and four active research projects with more than 750 participants. These studies are organized based on age of onset of Perthes’, since treatment options vary according to age. 1. 6-8 year age group: Study Question: Do surgical treatments produce better outcomes at 2 and 5 years post-treatment than non-surgical treatments? 2. 8-11 year age group: Study Question: Does a longer duration of non-weightbearing after hip surgery (using crutches and wheelchair for 6 weeks compared to 6 months) make a difference to the femoral head shape and outcome at 2 and 5 years? 3. >11 year age group: Study Question: Which of 3 treatments (multiple epiphyseal drilling +/- arthrodiastasis, non-surgical treatment) produce better femoral head shape and outcomes at 2 and 5 years? 4. Value of MRI: Study Question: Can perfusion MRI provide early information about how well the patient will do? At the 2022 POSNA Annual Meeting in Vancouver, Canada, IPSG Founder Dr. Harry Kim also presented the patient-reported outcomes of a survey of over 900 adults who had childhood Perthes’ disease. Are you interested in learning more about IPSG or becoming a member? Visit Website | | SCFE Longitudinal, International Prospective (SLIP) Registry The SCFE Longitudinal, International Prospective (SLIP) Registry follows patients with SCFE with long-term follow-up. Globally, SLIP Registry includes 34 centres across 9 countries. 350+ PATIENTS 34 CENTRES 9 COUNTRIES 5 CONTINENTS Visit Website | | | Global Hip Dysplasia Registry (GHDR) The Global Hip Dysplasia Registry (GHDR) follows patients with developmental dysplasia of the hip with long-term follow-up. Globally, GHDR includes 40 centres across 11 countries. 5.4 K PATIENTS 40 CENTRES 11 COUNTRIES 5 CONTINENTS Visit Website | | | Funding Announcement: CIHR Project Grant Received to Support GHDR-Based RCT The Canadian Institute for Health Research (CIHR) has recently announced project grant funding in the amount of 1.09 million dollars to support a GHDR-based, international, multi-centre, non-inferiority, randomized control trial titled: Bracing versus observation for the treatment of radiologic dysplasia: A non-inferiority RCT. The project, which is the registry's inaugural RCT, will look at whether careful monitoring of an infant's hips can be just as good as bracing to ensure their hips improve for babies diagnosed with mild DDH under three months of age. If that is the case, then unnecessary treatment can be avoided, especially during that newborn bonding period. This will be the first study to look at this question, with babies being treated at fourteen different hospitals in seven different countries, so the results will make an impact on children and families worldwide. | ACCEPTED PODIUM ABSTRACTS | | Abstracts accepted at POSNA's Annual Meeting 2023 Comparing Periacetabular Osteotomy with and Without an Arthrotomy/Osteochondroplasty: A propensity matched analysis Nathan Houlihan; Tanner Thornton; Daniel Sucato, MD, MS; Jeffrey Nepple, MD; John Clohisy, MD; Wudbhav Sankar, MD Children’s Hospital of Philadelphia, Philadelphia, PA | | | Abstracts accepted at POSNA's Annual Meeting 2023 How Are Adults with Perthes Disease Functioning After a Total Hip Replacement? Results of an International Web-based Survey Michael Millis, MD; Bella Vakulenko-Lagun; Roi Almakias; Harry Kim, MD Texas Scottish Rite Hospital for Children, Dallas, TX Does Duration of Non-weightbearing After Femoral Varus Osteotomy Affect Radiographic Outcome at 2-Year Follow-up of 8 to 11 Yearold Patients with Legg-Calvé-Perthes Disease? An International Multicenter Prospective Study Harry Kim, MD; Hitesh Shah, MD; David Chong, MD; Kumar Singh; Ishaan Swarup, MD; Yasmin Hailer; Scott Yang, MD; Luiz Renato De Angeli; William Morris, MD; Candelaria Mercado; Chan-Hee Jo, PhD; Jennifer Laine, MD; Wudbhav Sankar, MD Texas Scottish Rite Hospital for Children, Dallas, TX | | | | Abstract accepted at POSNA's Annual Meeting 2023 & COA 2023 Proportion of obesity in stable SCFE is higher than in unstable SCFE: A multi-centre, international prospective registry study Emily K Schaeffer, Bryn Zomar, Eduardo Novais, David Bade, Wudbhav Sankar, Kevin Smit, Debra Bartley, Kishore Mulpuri, SLIP Study Group | | | Abstract accepted at POSNA's Annual Meeting 2023 A prospective, multicenter study of developmental dysplasia of the hip: What can patients expect after open reduction? Sara N. Kiani, Alex L. Gornitzky, Travis H. Matheney, Emily K. Schaeffer, Kishore Mulpuri, Hitesh H. Shah, Ge Yihua, Vidyadhar Upasani, Alaric Aroojis, Venkatadass Krishnamoorthy, Global Hip Dysplasia Registry, & Wudbhav Sankar Abstract accepted at POSNA's Annual Meeting 2023 & EPOS 2023 Predictors of avascular necrosis of the femoral head following closed or open reduction in the treatment of developmental dysplasia of the hip Ethan Ponton, Jeffrey Bone, Wudbhav Sankar, Kishore Mulpuri, GHD Study Group, Emily K Schaeffer Abstract accepted at POSNA's Annual Meeting 2023, EPOS 2023, & COA 2023 Identification of predictors for the development of femoral nerve palsy in brace treatment for developmental dysplasia of the hip Emily K Schaeffer, Jack Hu, Vuong Nguyen, Wudbhav Sankar, Simon P Kelley, Nicole Williams, Kishore Mulpuri, GHD Study Group | | | Upasani VV, Bomar JD, Fitzgerald RE, Schupper AJ, Kelley SP; International Hip Dysplasia Registry. Prolonged Brace Treatment Does Not Result in Improved Acetabular Indices in Infantile Dislocated Hips. J Pediatr Orthop. 2022 May-Jun 01;42(5):e409-e413. doi: 10.1097/BPO.0000000000002110. PMID: 35200217. Link to Full-Text | | Li J, Aroojis A, Mulpuri K, Shea KG, Schaeffer EK. Development of a DDH Care Pathway for India: A Study Methodology to Guide Similar Efforts in Other Countries and for Other Conditions. Indian J Orthop. 2021 Oct 22;55(6):1549-1558. doi: 10.1007/s43465-021-00534-y. PMID: 34720173; PMCID: PMC8533670. Link to Full-Text | | | Pinto D, Aroojis A, Shah H, Patwardhan S, Venkatadass K, Sahu C, Schaeffer E, Mulpuri K. Demographic and Practice Variability Amongst Indian Centres in a Multicentre Prospective Observational Study on Developmental Dysplasia of the Hip. Indian J Orthop. 2021 Sep 20;55(6):1559-1567. doi: 10.1007/s43465-021-00516-0. PMID: 35003542; PMCID: PMC8688623. Link to Full-Text | | | | Schaeffer EK, Ponton E, Sankar WN, Kim HKW, Kelley SP, Cundy PJ, Price CT, Clarke NMP, Wedge JH, Mulpuri K; International Hip Dysplasia (IHD) Study Group. Interobserver and Intraobserver Reliability in the Salter Classification of Avascular Necrosis of the Femoral Head in Developmental Dysplasia of the Hip. J Pediatr Orthop. 2022 Jan 1;42(1):e59-e64. doi: 10.1097/BPO.0000000000001979. PMID: 34889834; PMCID: PMC8663514. Link to Full-Text | | | Mulpuri K, Schaeffer EK, Price CT. Global Collaborations in Developmental Dysplasia of the Hip. Indian J Orthop. 2021 Sep 4;55(6):1357-1359. doi: 10.1007/s43465-021-00504-4. PMID: 34987722; PMCID: PMC8688595 Link to Full-Text | | | | | | |